Cargando…
Treating severe asthma: Targeting the IL‐5 pathway
Severe asthma is a heterogeneous disease with different phenotypes based on clinical, functional or inflammatory parameters. In particular, the eosinophilic phenotype is associated with type 2 inflammation and increased levels of interleukin (IL)‐4, IL‐5 and IL‐13). Monoclonal antibodies that target...
Autores principales: | Principe, Stefania, Porsbjerg, Celeste, Bolm Ditlev, Sisse, Kjærsgaard Klein, Ditte, Golebski, Korneliusz, Dyhre‐Petersen, Nanna, van Dijk, Yoni E., van Bragt, Job J.M.H., Dankelman, Lente L.H., Dahlen, Sven‐Erik, Brightling, Christopher E., Vijverberg, Susanne J.H., Maitland‐van der Zee, Anke H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453879/ https://www.ncbi.nlm.nih.gov/pubmed/33887082 http://dx.doi.org/10.1111/cea.13885 |
Ejemplares similares
-
The Influence of Smoking Status on Exhaled Breath Profiles in Asthma and COPD Patients
por: Principe, Stefania, et al.
Publicado: (2021) -
Developments in the Management of Severe Asthma in Children and Adolescents: Focus on Dupilumab and Tezepelumab
por: van Dijk, Yoni E., et al.
Publicado: (2023) -
SHARP: enabling generation of real-world evidence on a pan-European scale to improve the lives of individuals with severe asthma
por: van Bragt, Job J.M.H., et al.
Publicado: (2021) -
Childhood asthma in the new omics era: challenges and perspectives
por: Golebski, Korneliusz, et al.
Publicado: (2020) -
Exhaled Metabolite Patterns to Identify Recent Asthma Exacerbations
por: van Bragt, Job J. M. H., et al.
Publicado: (2021)